← Open Payments lookup

DEBRA GIBSON: Open Payments

NPI 1811694482 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,257 in 80 payments from 10 companies in 2025. Trend: 2023 $197 · 2024 $1,000 · 2025 $2,257

Food & beverage: $2,255Education: $1
CompanyPaymentsAmount
ABBVIE INC.32$754
Otsuka America Pharmaceutical, Inc.14$464
Alkermes, Inc.12$347
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$285
Vanda Pharmaceuticals Inc.7$191
Janssen Pharmaceuticals, Inc4$105
Biogen, Inc.2$56
Braeburn Inc.1$23
Axsome Therapeutics, Inc.1$17
Lundbeck LLC1$15

Products named: VRAYLAR, ARISTADA, CAPLYTA, ABILIFY MAINTENA, FANAPT, REXULTI, ABILIFY ASIMTUFII, SPRAVATO.

Industry payments across AZ — which companies pay providers there.